Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuro-Consil is a specialized neurological private clinic and clinical research center based in Düsseldorf, Germany. Founded in 2000 by Prof. Dr. Andreas Hufnagel, the company provides comprehensive diagnostic and therapeutic services for a wide range of neurological and psychiatric disorders, including epilepsy, multiple sclerosis, and Parkinson's disease. In addition to patient care, Neuro-Consil GmbH operates as a clinical trial site, collaborating with major pharmaceutical companies such as Pfizer, Biogen, and Merck KGaA on Phase 2 and Phase 3 clinical studies. The center integrates advanced diagnostics like MRI, EEG, and sleep laboratory services with specialized treatments such as botulinum toxin therapy and cognitive training. It also offers a dedicated program for international patients and provides expert online video consultations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuro-Consil.